By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Immune Pharma Release: New Data Shows That Ceplene Enhances Response To Anti PD-1 And Anti-PD-L1 Immune Checkpoint Inhibitors In Lymphoma And Solid Tumor Models 6/21/2016 6:14:38 AM
Immune Pharma To Present At The JMP Securities Life Sciences Conference On June 21, 2016 6/20/2016 7:34:25 AM
Immune Pharma Expands Its Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid To Six Academic Institutions In The United States 6/15/2016 10:11:18 AM
Immune Pharma And Hadasit Ltd. File A Joint Patent On The Oral Use Of Anti-Eotaxin Monoclonal Antibodies, Including Bertilimumab, For The Treatment Of GI And Liver Diseases 6/8/2016 7:47:10 AM
Immune Pharma Provides Business And R&D Update And Announces First Quarter 2016 Financial Results 5/16/2016 7:46:43 AM
Immune Pharma Release: New Biomarker Data To Be Presented At AACR Helps Predict Overall Survival In Patients With Acute Myeloid Leukemia (AML) Treated With Ceplene And Low-Dose IL-2 Immunotherapy, Including Those Over 60 Years Of Age 4/19/2016 9:53:28 AM
Immune Pharma Provides Business Update And Announces Fourth Quarter And Full Year 2015 Financial Results 3/31/2016 9:22:58 AM
Immune Pharma Announces Publication Of Preclinical Data In Support Of Its Bispecific Antibody Platform In The Journal Of Immunology 3/22/2016 6:44:09 AM
Immune Pharma Release: New Data On Ceplene Cancer Immunotherapy To Be Presented At The 2016 AACR Annual Meeting 3/18/2016 6:54:59 AM
Immune Pharma Release: New Data On Ceplene Cancer Immunotherapy To Be Presented At The 2016 AACR Annual Meeting 3/17/2016 8:31:10 AM
12345678910...
//-->